At a glance
ClinicalIndex Comparison RecordN/ACompleted· 414 enrolled
Drug / intervention
use of the MP5 EWS patient monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of IntelliVue Patient Monitor MP5 Rel. G.1 for the Prevention of "Failure to Rescue" Using Early Warning Score
In Brief
An observational study evaluating use of the MP5 EWS patient monitor for Sepsis and 3 related conditions. Completed, enrolled 414 participants across 1 site.
Detailed Summary
The purpose of this study is to assess if, compared with standard paper-based systems, an automated Early Warning System (EWS) resident in a spot check patient monitor, can help to identify deteriorating patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis, Renal Failure, Pulmonary Edema, Cardio-pulmonary Arrest
CountriesAustralia
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2009
Primary CompletionMay 2010
Study CompletionJun 2010
First PostedSep 2010
TodayJul 2026
First PostedSep 9, 2010
Enrollment StartAug 1, 2009
Primary CompletionMay 1, 2010
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.8 years ago
Interventions
use of the MP5 EWS patient monitordevice
All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.